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Several nucleoside analogs are well-known to inhibit the reverse 
transcription (RT) process in HIV by terminating the synthesis of a 
proviral DNA strand. Recently, Herdewijn and coworkers showed 
that some L-2-deoxythreose nucleoside phosphonates (a; Figure 
1) selectively inhibit HIV
 
without affecting human DNA synthesis.
1
 
These nucleoside analogues require two additional 
phosphorylation steps by cellular kinases before they are 
incorporated in the viral genome and lead to chain termination.  It 
is believed that a cis orientation of the base and the 3’-substituent 
is a structural requirement for optimal conversion to the 
diphosphate. Inspired by these findings, we decided to explore 
the antiviral properties of the threose-based nucleoside analogues 
(b; Figure 1), which are anticipated to have superior bioavailability compared to the parent 
phosphonates. Remarkably, such α-L-2’-deoxythreofuranosyl analogues (exhibiting a 1’R,3’R 
configuration) have not been reported before. 
 
The synthesis of the desired T, U, C and A analogs (Scheme-1), were completed involving a 
Vorbrüggen coupling 
2
 and a Barton-McCombie deoxygenation 
3
 as key steps. The synthetic course 
also revealed the importance of proper protecting groups. 
 
 
Scheme-1 
 
 
All the α-L-2’-deoxythreofuranosyl analogues synthesized were evaluated in vitro for cytotoxicity and 
for their activity against a variety of viruses, while their capacity to inhibit a panel of 
deoxyribonucleoside kinases was also assessed.  
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